Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.

PREMARKET POST MEMORIAL: IntelliPharmaCeutics Intl Inc USA, Prima Biomed Ltd., Rewalk Robotics Ltd


New York, NY – May 26, 2015
OTCFire.com provides it’s members with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, and hidden stocks traded on the NASDAQ, NYSE, AMEX, and OTC Markets with the potential of fast gains.

Make 700% Gains, subscribe for free at http://www.otcfire.com

OTCFire.com has issued a news alert on the following PREMARKET POST MEMORIAL;

IntelliPharmaCeutics Intl Inc USA (NASDAQ:IPCI) is currently trading at $3.1 down 0.0%.
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is at the core of its controlled-release drug delivery approach.

Prima Biomed Ltd. (NASDAQ:PBMD) is currently trading at $3.15 down 0.0%.

Rewalk Robotics Ltd (NASDAQ:RWLK) is currently trading at $13.35 down 0.0%.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again.

Hot Stocks To Watch

OTCFire.com is working on its next Hot Stocks To Watch Special Report. These Special Reports typically see fast gains. Reports are issued to members only, Go to http://www.otcfire.com to subscribe for free.

Disclosure
OTCFire.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. This press release may contain several forward looking statements. Please visit our website for complete risks and disclosures.

Site Preview:

 

Related Press realease: